Platelet monoamine oxidase in schizophrenia: a meta-analysis-Reference-Cited by-同舟云学术

Platelet monoamine oxidase in schizophrenia: a meta-analysis

Published:1992-09 Issue:3 Volume:7 Page:249-267
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Marcolin Marco Antonio,Davis John M.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference156 articles.

1. Studies of MAO concentration and activity in schizophrenic patients;Abell,1978

2. Platelet MAO activity: Relationships to clinical and psychometric variables;Adler;Schizophr. Bull.,1980

3. Platelet monoamine oxidase in a pedigree with schizophrenia: an inter-laboratory project;Ask;Clin. Gen.,1979

4. Platelet monoamine oxidase activity in patients with chronic schizophrenic illness untreated by neuroleptic drugs;Bailey;Br. J. Clin. Pharmacol.,1975

5. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs;Bailey,1975

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations;European Neuropsychopharmacology;2023-07

2. Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example;Advances in Neurobiology;2023

3. Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors and their role in the history of psychopharmacology;Frontiers in Pharmacology;2022-12-06

4. Review and meta-analysis of add-on tranylcypromine with antipsychotic drugs for the treatment of schizophrenia with predominant negative symptoms: a restoration of evidence;Current Medical Research and Opinion;2021-05-20

5. Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome;Platelets;2017-06-29